AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Bio Green Med Solution, Inc. Director's Dealing 2018

Jun 4, 2018

Director's Dealing

Opens in your device viewer

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2018-05-31

Reporting Person: BARKER SAM L (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-31	Stock Option (right to buy)	$1.42	A	8576	Acquired	2028-05-31	Common Stock (8576)	Direct

F1: These options were granted to Dr. Barker for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.